The Veterinary API Market is expected to record a CAGR of 7.7% from 2024 to 2031, reaching $ 15.84 billion by 2031. Veterinary active pharmaceutical ingredients (APIs) are integral to the animal pharmaceutical industry as they are needed to manufacture finished veterinary drugs or formulations to treat and prevent diseases and disorders in animals. The growth of the veterinary API market is driven by the growing expenditure on animal health, the rising prevalence of animal, foodborne, and zoonotic diseases, and the growing demand for animal-derived food products globally. Additionally, increasing awareness regarding animal health in emerging economies and the growing application of precision medicine in veterinary care are expected to create growth opportunities for the stakeholders in this market. However, the stringent regulatory approval process restrains the growth of this market. The environmental impact of veterinary drugs and the dearth of veterinary practitioners is a major challenge to market growth.
The demand for animal-derived food products, namely meat, milk, and eggs, has increased. The consumption of animal-derived foods is increasing due to decreasing agricultural productivity due to shrinking resources and reduced availability of cultivable land. Food products derived from animals are a major source of protein, and a protein-rich diet is essential to leading a healthy life.
Consumption of animal proteins is stable (around 44 to 55 g/capita/day) in developed countries, while consumption is increasing in developing countries. For instance, in 2020, the U.S. accounted for approximately 21% of global beef consumption. In 2020, beef and veal consumption in Asia reached 19,656.46 thousand tons and is expected to increase to 21,467.08 thousand tons by 2026 (Source: OECD FAO). Farmers are expected to increase livestock production to meet the increasing demand for animal-derived foods. Increased livestock production will encourage the adoption of pharmaceuticals for animals. Several animal pharmaceuticals are used for their overall health, such as vaccines, parasiticides, and medicines for other diseases and conditions to prevent the spread of disease and improve animal health. This is one of the major factors driving the market growth.
The increasing number of livestock/farm animals poses a higher risk of diseases and infections that can cross the species barrier and be passed on to humans through direct contact or the consumption of livestock products. Over the last century, there has been an alarming increase in the number, frequency, and diversity of zoonotic disease outbreaks. Caused by the spillover of pathogens from animal hosts to people, these events may have more than tripled in the last decade, with the number of new zoonotic diseases infecting people quadrupling over the same period.
Over 150 zoonotic diseases can be transmitted to humans by wild and domestic animal populations, 13 of which are responsible for 2.2 million deaths per year. Viruses, bacteria, parasites, and fungi cause zoonotic diseases. These germs can cause many illnesses in people and animals, ranging from mild to serious illnesses and even death. Depending on the disease, animals can sometimes appear healthy, even when carrying pathogens that can make people sick.
Furthermore, although pet animals are considered a part of the family, they can be carriers of diseases that infect humans. Diseases transmitted from animals to humans mainly spread through vectors, such as flies, ticks, fleas, and mosquitoes. Therefore, pet owners are growing increasingly concerned regarding the health and well-being of their companion animals, driving the adoption of medicines and drugs required for their well-being. Therefore, the growing prevalence of diseases in animals and the high risk of zoonotic diseases leads to adopting appropriate veterinary drugs to curb the spread of these diseases. This is expected to generate a demand for veterinary APIs for manufacturing these drugs, driving the market globally.
Click here to: Get Free Sample Pages of this Report
Parasiticides such as ectoparasiticides, endoparasiticides, and endectocides are used against the infections of parasitic organisms, including tapeworms, hookworms, roundworms, mites, fleas, ticks, flukes, and other parasites. Companion animals, as well as farm animals, are very commonly affected by these parasites. Therefore, it becomes crucial to administer the parasiticides at regular intervals to keep the animal healthy and disease-free, supporting a large share of the segment. Moreover, factors such as the increasing prevalence of zoonotic diseases, growing demand for animal-derived food products, and increasing number of livestock in emerging economies also support the large share of the segment.
The factors attributed to the segment’s large share are control & precision, scale-up, cost efficiency, and consistency of the chemical API synthesis method. Chemical synthesis methods can be efficient and cost-effective for producing large quantities of APIs. Once the route for the synthesis of a compound is set, the manufacturers can scale up the production process, which helps the manufacturers reduce the production costs, leading to higher profit margins. This cannot be achieved for biologically synthesized APIs as they require specific methodologies and techniques to obtain the desired molecule.
Based on animal type, the veterinary API market is segmented into companion animals and livestock. In 2024, the companion animals segment is expected to account for the largest share of the veterinary API market. People need a companion for emotional well-being, and pets offer a positive environment at home. There is a common trend of owning a pet amongst people globally. According to Animal Medicines Australia, pet ownership in Australia increased to 69% of households having pets in 2021 from 61% in 2019. This increase led to a rise in pet-related expenditures & adoption of pet insurance in Australia. For instance, the average household insurance expenditure for dogs in Australia increased from USD 147 in 2019 to USD 246 in 2021. Similarly, the percentage of households who owned dog pets in the U.K. accounted for 31% of the total households (Source: World Animal Foundation). Additionally, in 2022, the total number of pets in Brazil accounted for 167.6 million (Source: ABINPET).
In 2023, North America is expected to dominate the veterinary API market, while Asia-Pacific is expected to record the highest CAGR of 8.3% during the forecast period. The high growth of the Asia-Pacific veterinary API market is attributed to the growing population of pet animals, growing demand and consumption of animal-derived food proteins, presence of large exporters of animal products, government initiatives to improve agricultural and animal husbandry outcomes, and the rising incidence of various zoonotic diseases in the region.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in the last three to four years. The key players profiled in the veterinary API market are Alivira Animal Health Limited (India), Excel Industries Ltd. (India), Suan Farma, S.A.U. (Spain), Chr. Olesen (Denmark), Qilu Pharmaceutical Co., Ltd. (China), FIS - Fabbrica Italiana Sintetici S.p.A. (Italy), Rochem International Inc. (U.S.), NGL Fine-Chem Ltd. (India), MENADIONA S.L (Spain), and Chempro Pharma Private Limited. (India).
|
Particular |
Details |
|
Page No |
~225 |
|
Format |
|
|
Forecast Period |
2024-2031 |
|
Base Year |
2023 |
|
CAGR |
7.7% |
|
Market Size (Value) |
$15.84 billion by 2031 |
|
Segments Covered |
By Product
By Synthesis Type
By Animal Type
|
|
Countries/Regions Covered |
North America (U.S. and Canada), Europe (Germany, France, U.K., Spain, Italy, Switzerland, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of APAC), Latin America (Brazil, Mexico, and Rest of LATAM), Middle East & Africa (Saudi Arabia, UAE, and South Africa) |
|
Key Companies |
Alivira Animal Health Limited (India), Excel Industries Ltd. (India), Suan Farma, S.A.U. (Spain), Chr. Olesen (Denmark), Qilu Pharmaceutical Co., Ltd. (China), FIS - Fabbrica Italiana Sintetici S.p.A. (Italy), Rochem International Inc. (U.S.), NGL Fine-Chem Ltd. (India), MENADIONA S.L (Spain), and Chempro Pharma Private Limited. (India). |
The veterinary API market report covers market sizes & forecasts for parasiticides, vaccines, antibiotics, anti-inflammatories, and other APIs. The veterinary API market study includes the value analysis of various segments and subsegments of the veterinary API market at the regional and country levels. Additionally, regulatory analysis, pipeline analysis, PESTEL analysis, and trends are provided for the veterinary API market. The report also provides a competitive landscape for the players operating in the market.
The veterinary API market is projected to reach $15.84 billion by 2031, at a CAGR of 7.7% from 2024 to 2031.
The parasiticides segment is estimated to account for the largest share of the veterinary API market in 2024.
Based on animal type, the companion animals segment is projected to gain more traction in the veterinary API market.
The high growth of the veterinary API market is mainly attributed to the growing expenditure on animal health, the rising prevalence of animal, foodborne, and zoonotic diseases, and the growing demand for animal-derived food products globally. Additionally, increasing awareness regarding animal health in emerging economies and the growing application of precision medicine in veterinary care are expected to create growth opportunities for the stakeholders in this market.
The key players operating in the veterinary API market are Alivira Animal Health Limited (India), Excel Industries Ltd. (India), Suan Farma, S.A.U. (Spain), Chr. Olesen (Denmark), Qilu Pharmaceutical Co., Ltd. (China), FIS - Fabbrica Italiana Sintetici S.p.A. (Italy), Rochem International Inc. (U.S.), NGL Fine-Chem Ltd. (India), MENADIONA S.L (Spain), and Chempro Pharma Private Limited. (India).
The emerging Asian-Pacific countries are expected to offer significant growth opportunities for the vendors in this market due to the growing population of pet animals, growing demand and consummation of animal-derived food proteins, presence of large exporters of animal products, government initiatives to improve agricultural and animal husbandry outcomes, and the rising incidence of various zoonotic diseases in the region.
This report provides pre & post COVID-19 market estimates.
1. Introduction
1.1. Market Definition and Scope
1.2. Market Ecosystem
1.3. Currency and Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for this Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Growing Expenditure on Animal Health
4.2.2. Rising Prevalence of Zoonotic and Foodborne Diseases
4.2.3. Rising Demand for Animal-derived Food Products
4.3. Restraints
4.3.1. Stringent Regulatory Approval Process
4.4. Opportunity
4.4.1. Growing Awareness Regarding Animal Health in Emerging Economies
4.4.2. Growing Application of Precision Medicine in Veterinary Care
4.5. Challenges
4.5.1. Environmental Impacts of Veterinary Drugs
4.5.2. Dearth of Veterinary Practitioners
4.6. Trends
4.7. Regulatory Analysis
4.8. Pipeline Analysis
4.9. PESTEL Analysis
5. Veterinary Active Pharmaceutical Ingredients Market Assessment—by Type
5.1. Overview
5.2. Parasiticides
5.2.1. Albendazole
5.2.2. Clorsulon
5.2.3. Ivermectin
5.2.4. Moxidectin
5.2.5. Fipronil
5.2.6. Other Parasiticide APIs
5.3. Vaccines
5.4. Antibiotics
5.4.1. Penicillin
5.4.2. Trimethoprim-sulfa
5.4.3. Cephalexin
5.4.4. Enrofloxacin
5.4.5. Other Antibiotic APIs
5.5. Anti-inflammatory
5.5.1. Carprofen
5.5.2. Deracoxib
5.5.3. Firocoxib
5.5.4. Meloxicam
5.5.5. Other Anti-inflammatory APIs
5.6. Other Types
5.6.1. Oxycodone
5.6.2. Hydromorphone
5.6.3. Pimobendan
5.6.4. Levothyroxine
6. Veterinary Active Pharmaceutical Ingredients Market Assessment—by Synthesis Type
6.1. Overview
6.2. Chemical APIs
6.3. Biological APIs
6.4. High Potent APIs
7. Veterinary Active Pharmaceutical Ingredients Market Assessment—by Animal Type
7.1. Overview
7.2. Companion Animals
7.3. Livestock
8. Veterinary Active Pharmaceutical Ingredients Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Switzerland
8.3.7. Rest of Europe
8.4. Asia-Pacific
8.4.1. Japan
8.4.2. China
8.4.3. India
8.4.4. Australia
8.4.5. South Korea
8.4.6. Rest of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East and Africa
8.6.1. Saudi Arabia
8.6.2. South Africa
8.6.3. Rest of Middle East and Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4 . Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis, by the Key Player/Key Market Ranking, 2023
10. Company Profiles (Company Overview, Financial Overview, Product Portfolio, Strategic Developments, and SWOT Analysis*)
10.1. Alivira Animal Health Limited
10.2. Excel Industries Ltd.
10.3. Suan Farma, S.A.U.
10.4. Chr. Olesen
10.5. Qilu Pharmaceutical Co., Ltd.
10.6. FIS - Fabbrica Italiana Sintetici S.p.A.
10.7. Rochem International Inc.
10.8. NGL Fine-Chem Ltd.
10.9. MENADIONA S.L
10.10. Chempro Pharma Private Limited.
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Global Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 2 Global Veterinary Parasiticides API Market, by Country/Region, 2022–2031 (USD Million)
Table 3 Global Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 4 Global Veterinary Albendazole Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Veterinary Clorsulon Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Veterinary Ivermectin Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Veterinary Moxidectin Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Veterinary Fipronil Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Other Veterinary Parasiticides APIs Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Veterinary Antibiotics API Market, by Country/Region, 2022–2031 (USD Million)
Table 11 Global Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 12 Global Veterinary Penicillin Market, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Veterinary Trimethoprim-sulfa Market, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Veterinary Cephalexin Market, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Veterinary Enrofloxacin Market, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Other Veterinary Antibiotics APIs Market, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Veterinary Vaccine API Market, by Country/Region, 2022–2031 (USD Million)
Table 18 Global Veterinary Anti-inflammatory API Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 20 Global Veterinary Carprofen Market, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Veterinary Deracoxib Market, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Veterinary Firocoxib Market, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Veterinary Meloxicam Market, by Country/Region, 2022–2031 (USD Million)
Table 24 Global Other Veterinary Anti-inflammatory APIs Market, by Country/Region, 2022–2031 (USD Million)
Table 25 Global Other Veterinary APIs Market, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 27 Global Veterinary Oxycodone Market, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Veterinary Hydromorphone Market, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Veterinary Pimobendan Market, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Veterinary Levothyroxine Market, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Other Veterinary APIs Market, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 33 Global Veterinary Chemical APIs Market, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Veterinary Biological APIs Market, by Country/Region, 2022–2031 (USD Million)
Table 35 Global Veterinary High Potent APIs Market, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 37 Global Veterinary Active Pharmaceutical Ingredients Market for Livestock, by Country/Region, 2022–2031 (USD Million)
Table 38 Veterinary Active Pharmaceutical Ingredients Market for Companion Animals, by Country/Region, 2022–2031 (USD Million)
Table 39 North America: Veterinary Active Pharmaceutical Ingredients Market, by Country, 2022–2031 (USD Million)
Table 40 North America: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 41 North America: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 42 North America: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 43 North America: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 44 North America: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 45 North America: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 46 North America: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 47 U.S.: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 48 U.S.: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 49 U.S.: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 50 U.S.: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 51 U.S.: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 52 U.S.: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 53 U.S.: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 54 Canada: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 55 Canada: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 56 Canada: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 57 Canada: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 58 Canada: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 59 Canada: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 60 Canada: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 61 Europe: Veterinary Active Pharmaceutical Ingredients Market, by Country/Region, 2022–2031 (USD Million)
Table 62 Europe: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 63 Europe: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 64 Europe: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 65 Europe: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 66 Europe: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 67 Europe: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 68 Europe: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 69 Germany: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 70 Germany: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 71 Germany: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 72 Germany: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 73 Germany: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 74 Germany: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 ( USD Million)
Table 75 Germany: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 76 France: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 77 France: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 78 France: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 79 France: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 80 France: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 81 France: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 82 France: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 83 U.K.: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 84 U.K.: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 85 U.K.: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 86 U.K.: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 87 U.K.: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 88 U.K.: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 89 U.K.: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 90 Italy: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 91 Italy: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 92 Italy: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 93 Italy: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 94 Italy: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 95 Italy: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 96 Italy: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 97 Spain: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 98 Spain: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 99 Spain: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 100 Spain: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 101 Spain: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 102 Spain: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 103 Spain: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 104 Switzerland: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 105 Switzerland: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 106 Switzerland: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 107 Switzerland: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 108 Switzerland: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 109 Switzerland: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 110 Switzerland: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 111 RoE: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 112 RoE: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 113 RoE: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 114 RoE: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 115 RoE: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 116 RoE: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 117 RoE: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 118 Asia-Pacific: Veterinary Active Pharmaceutical Ingredients Market, by Country, 2022–2031 (USD Million)
Table 119 Asia-Pacific: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 120 Asia-Pacific: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 121 Asia-Pacific: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 122 Asia-Pacific: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 123 Asia-Pacific: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 124 Asia-Pacific: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 125 Asia-Pacific: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 126 Japan: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 127 Japan: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 128 Japan: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 129 Japan: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 130 Japan: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 131 Japan: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 132 Japan: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 133 China: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 134 China: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 135 China: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 136 China: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 137 China: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 138 China: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 139 China: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 140 India: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 141 India: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 142 India: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 143 India: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 144 India: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 145 India: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 146 India: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 147 Australia: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 148 Australia: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 149 Australia: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 150 Australia: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 151 Australia: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 152 Australia: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 153 Australia: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 154 South Korea: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 155 South Korea: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 156 South Korea: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 157 South Korea: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 158 South Korea: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 159 South Korea: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 160 South Korea: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 161 RoAPAC: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 162 RoAPAC: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 163 RoAPAC: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 164 RoAPAC: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 165 RoAPAC: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 166 RoAPAC: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 167 RoAPAC: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 168 Latin America: Veterinary Active Pharmaceutical Ingredients Market, by Country, 2022–2031 (USD Million)
Table 169 Latin America: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 170 Latin America: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 171 Latin America: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 172 Latin America: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 173 Latin America: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 174 Latin America: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 175 Latin America: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 176 Brazil: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 177 Brazil: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 178 Brazil: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 179 Brazil: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 180 Brazil: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 181 Brazil: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 182 Brazil: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 183 Mexico: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 184 Mexico: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 185 Mexico: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 186 Mexico: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 187 Mexico: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 188 Mexico: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 189 Mexico: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 190 RoLATAM: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 191 RoLATAM: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 192 RoLATAM: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 193 RoLATAM: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 194 RoLATAM: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 195 RoLATAM: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 196 RoLATAM: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 197 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Market, by Country/Region, 2022–2031 (USD Million)
Table 198 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 199 Middle East & Africa: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 200 Middle East & Africa: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 201 Middle East & Africa: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 202 Middle East & Africa: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 203 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 204 Middle East & Africa: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 205 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 206 Saudi Arabia: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 207 Saudi Arabia: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 208 Saudi Arabia: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 209 Saudi Arabia: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 210 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 211 Saudi Arabia: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 212 UAE: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 213 UAE: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 214 UAE: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 215 UAE: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 216 UAE: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 217 UAE: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 218 UAE: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 219 South Africa: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 220 South Africa: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 221 South Africa: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 222 South Africa: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 223 South Africa: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 224 South Africa: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 225 South Africa: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 226 RoMEA: Veterinary Active Pharmaceutical Ingredients Market, by Type, 2022–2031 (USD Million)
Table 227 RoMEA: Veterinary Parasiticides API Market, by Type, 2022–2031 (USD Million)
Table 228 RoMEA: Veterinary Antibiotics API Market, by Type, 2022–2031 (USD Million)
Table 229 RoMEA: Veterinary Anti-inflammatory API Market, by Type, 2022–2031 (USD Million)
Table 230 RoMEA: Other Veterinary APIs Market, by Type, 2022–2031 (USD Million)
Table 231 RoMEA: Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2022–2031 (USD Million)
Table 232 RoMEA: Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2022–2031 (USD Million)
Table 233 Recent Developments, by Company (2021–2024)
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Veterinary Active Pharmaceutical Ingredients Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 8 Global Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2024 Vs. 2031 (USD Million)
Figure 9 Global Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2024 Vs. 2031 (USD Million)
Figure 10 Global Veterinary Active Pharmaceutical Ingredients Market, by Geography
Figure 11 Market Dynamics: Veterinary Active Pharmaceutical Ingredients Market
Figure 12 Global Veterinary Active Pharmaceutical Ingredients Market, by Type, 2024 Vs. 2031 (USD Million)
Figure 13 Global Veterinary Active Pharmaceutical Ingredients Market, by Synthesis Type, 2024 Vs. 2031 (USD Million)
Figure 14 Global Veterinary Active Pharmaceutical Ingredients Market, by Animal Type, 2024 Vs. 2031 (USD Million)
Figure 15 Global Veterinary Active Pharmaceutical Ingredients Market, by Geography, 2024 Vs. 2031 (USD Million)
Figure 16 Canada: Veterinary Active Pharmaceutical Ingredients Market Snapshot
Figure 17 Europe: Veterinary Active Pharmaceutical Ingredients Market Snapshot
Figure 18 Asia-Pacific: Veterinary Active Pharmaceutical Ingredients Market Snapshot
Figure 19 Latin America: Veterinary Active Pharmaceutical Ingredients Market Snapshot
Figure 20 Key Growth Strategies Adopted by Leading Players (2021–2024)
Figure 21 Global Veterinary Active Pharmaceutical Ingredients Market: Competitive Benchmarking Based on Type
Figure 22 Global Veterinary Active Pharmaceutical Ingredients Market: Competitive Benchmarking Based on Geography
Figure 24 SeQuent Scientific Ltd.: Financial Overview (2023)
Figure 25 Excel Industries Ltd.: Financial Overview (2023)
Figure 26 NGL Fine-Chem Ltd.: Financial Overview (2023)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Aug-2023
Published Date: Jan-2023
Published Date: Jun-2022
